| Clinical Study "Common" Name (formal title) | Number of enrollees | Funding source (pharma/NIH) | Year complete | Primary publication | Full study treatment protocol |
|---|---|---|---|---|---|
| BRAVO (RanibizumaB for the Treatment of Macular Edema following BRAnch Retinal Vein Occlusion study) | 397 | Genentech | 2009 |
Campochiaro PA, Heier JS, Feiner L, et al. Ranibizumab for Macular Edema Following Branch Retinal Vein Occlusion: Six-Month Primary End Point Results of a Phase Iii Study. Ophthalmology 2010;117:1102-1112 e1.
|
|